Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Liver Diseases

  Free Subscription

Articles published in Indian J Gastroenterol

Retrieve available abstracts of 30 articles:
HTML format

Single Articles

    August 2021
  1. DUTTA D, Tatineni T, Yarlagadda S, Gupte A, et al
    Hepatocellular carcinoma patients with portal vein thrombosis treated with robotic radiosurgery: Interim results of a prospective study.
    Indian J Gastroenterol. 2021;40:389-401.
    PubMed     Abstract available

    July 2021
  2. RAJESH S, Philips CA, Betgeri SS, George T, et al
    Transjugular intrahepatic portosystemic shunt (TIPS) placement at index portal hypertensive decompensation (anticipant TIPS) in cirrhosis and the role of early intervention in variceal bleeding and ascites.
    Indian J Gastroenterol. 2021 Jul 29. pii: 10.1007/s12664-021-01179.
    PubMed     Abstract available

    June 2021
  3. RATTANASUPAR A, Chang A, Akarapatima K, Chaojin T, et al
    Role of lactulose for prophylaxis against hepatic encephalopathy in cirrhotic patients with upper gastrointestinal bleeding: A randomized trial.
    Indian J Gastroenterol. 2021 Jun 15. pii: 10.1007/s12664-021-01150.
    PubMed     Abstract available

  4. SAITHANYAMURTHI HV, Munirathinam M, Ananthavadivelu M
    Prevalence of liver injury in 445 patients with Corona Virus Disease-19-Single-centre experience from southern India.
    Indian J Gastroenterol. 2021;40:303-308.
    PubMed     Abstract available

    May 2021
  5. PAMECHA V, Sinha PK, Rajendran V, Patil NS, et al
    Living donor liver transplantation for hepatocellular carcinoma in Indian patients- Is the scenario different?
    Indian J Gastroenterol. 2021 May 21. pii: 10.1007/s12664-020-01138.
    PubMed     Abstract available

  6. TAPADIA A, Jain M, Reddy MS, Mahadevan B, et al
    Serum C-reactive protein and neutrophil-to-lymphocyte ratio as predictors of survival in cirrhotic patients with systemic inflammatory response syndrome and bacterial infection.
    Indian J Gastroenterol. 2021 May 11. pii: 10.1007/s12664-020-01134.
    PubMed     Abstract available

    March 2021
  7. KEDARISETTY CK, Bhardwaj A, Kumar G, Rastogi A, et al
    Efficacy of combining pentoxiphylline and vitamin E versus vitamin E alone in non-alcoholic steatohepatitis- A randomized pilot study.
    Indian J Gastroenterol. 2021 Mar 27. pii: 10.1007/s12664-020-01131.
    PubMed     Abstract available

  8. SACHDEVA S, Sonika U, Dalal A, Sethi SS, et al
    Spontaneous giant biloma resulting from multifocal left hepatic duct perforation.
    Indian J Gastroenterol. 2021 Mar 5. pii: 10.1007/s12664-021-01154.

    February 2021
  9. RAJAKANNU M, Vij M, Shaikh TMA, Rammohan A, et al
    Prognostic impact of incidentally detected hepatocellular carcinoma in explanted livers after living donor liver transplantation.
    Indian J Gastroenterol. 2021 Feb 6. pii: 10.1007/s12664-020-01127.
    PubMed     Abstract available

  10. PHILIPS CA, Agarwal M, Rajesh S, Ahamed R, et al
    A novel homozygous frameshift variant in the ABCC2-gene in Dubin-Johnson syndrome may predispose to chronic liver disease.
    Indian J Gastroenterol. 2021;40:72-76.
    PubMed     Abstract available

  11. PRIYADARSHI RN, Anand U, Kumar R, Thakur SK, et al
    Ischemic jejunal stricture in patients with extrahepatic portal vein obstruction.
    Indian J Gastroenterol. 2021;40:82-87.
    PubMed     Abstract available

    January 2021
  12. BISWAS SN, Kulkarni A, Jain M, Chaudhary N, et al
    Intra-biliary rupture of hepatic hydatid cyst: An uncommon presentation of a common disease.
    Indian J Gastroenterol. 2021 Jan 2. pii: 10.1007/s12664-020-01130.

    November 2020
  13. PATAVOUKAS G, Samarkos M, Mavroudis A, Kavvouri D, et al
    Hepatosplenic cat scratch disease: The usefulness of liver biopsy.
    Indian J Gastroenterol. 2020 Nov 24. pii: 10.1007/s12664-020-01115.

  14. KAPOOR N, Mehta V, Singh B, Karna R, et al
    Prevalence of cirrhotic cardiomyopathy and its relationship with serum pro-brain natriuretic peptide, hepatorenal syndrome, spontaneous bacterial peritonitis, and mortality.
    Indian J Gastroenterol. 2020 Nov 13. pii: 10.1007/s12664-020-01083.
    PubMed     Abstract available

  15. KUMAR U, Kumar R, Jha SK, Jha AK, et al
    Short-term mortality in patients with cirrhosis of the liver and acute kidney injury: A prospective observational study.
    Indian J Gastroenterol. 2020 Nov 11. pii: 10.1007/s12664-020-01086.
    PubMed     Abstract available

    September 2020
  16. CHINDARATANA K, Tanpowpong P, Lertudomphonwanit C, Treepongkaruna S, et al
    Gastrointestinal protein loss in children with portal hypertension.
    Indian J Gastroenterol. 2020 Sep 24. pii: 10.1007/s12664-020-01079.
    PubMed     Abstract available

  17. PHILIPS CA, Rajesh S, George T, Ahamed R, et al
    Early, late, or no shunt embolization in patients with cirrhosis- and portosystemic shunt-related hepatic encephalopathy.
    Indian J Gastroenterol. 2020 Sep 15. pii: 10.1007/s12664-020-01042.
    PubMed     Abstract available

    August 2020
  18. KHIANGTE B, Kothakota SR, Sasidharan M, Kareem H, et al
    Prevalence and determinants of hepatopulmonary syndrome in decompensated chronic liver disease.
    Indian J Gastroenterol. 2020 Aug 25. pii: 10.1007/s12664-020-01052.
    PubMed     Abstract available

  19. SHALIMAR, Elhence A, Vaishnav M, Kumar R, et al
    Poor outcomes in patients with cirrhosis and Corona Virus Disease-19.
    Indian J Gastroenterol. 2020 Aug 15. pii: 10.1007/s12664-020-01074.
    PubMed     Abstract available

  20. KUMAR A, Arora A, Sharma P, Anikhindi SA, et al
    Gastrointestinal and hepatic manifestations of Corona Virus Disease-19 and their relationship to severe clinical course: A systematic review and meta-analysis.
    Indian J Gastroenterol. 2020 Aug 4. pii: 10.1007/s12664-020-01058.
    PubMed     Abstract available

    June 2020
  21. FARSHIDPOUR M, Kim D, Junna S, Merchant J, et al
    A brief review of liver injury in patients with Corona Virus Disease-19 during the pandemic.
    Indian J Gastroenterol. 2020;39:232-235.
    PubMed     Abstract available

  22. ELHENCE A, Shalimar
    Author's reply to comment on review article: Treatment of non-alcoholic fatty liver disease-Current perspectives.
    Indian J Gastroenterol. 2020;39:304.

    Non-alcoholic fatty liver and cancer.
    Indian J Gastroenterol. 2020;39:303.

    April 2020
  24. PHILIPS CA, Augustine P, Ahamed R, Rajesh S, et al
    Acute exacerbated severe form of nonalcoholic steatohepatitis leading to acute-on-chronic liver failure: A case series.
    Indian J Gastroenterol. 2020 Apr 14. pii: 10.1007/s12664-020-01028.
    PubMed     Abstract available

    March 2020
  25. LAZAR MV, Eapen M, Nair HR, Siyad I, et al
    Correlation between insulin resistance and liver histology in patients with nonalcoholic steatohepatitis with and without obesity.
    Indian J Gastroenterol. 2020 Mar 28. pii: 10.1007/s12664-020-01024.
    PubMed     Abstract available

    February 2020
  26. DELIK A, Akkiz H, Dincer S
    The effect of PNPLA3 polymorphism as gain in function mutation in the pathogenesis of non-alcoholic fatty liver disease.
    Indian J Gastroenterol. 2020;39:84-91.
    PubMed     Abstract available

  27. SINHA N, Mukhopadhyay S, Sau M
    Metabolic syndrome is not uncommon among lean non-alcoholic fatty liver disease patients as compared with those with obesity.
    Indian J Gastroenterol. 2020;39:75-83.
    PubMed     Abstract available

  28. GHOSHAL UC, Goel A, Quigley EMM
    Gut microbiota abnormalities, small intestinal bacterial overgrowth, and non-alcoholic fatty liver disease: An emerging paradigm.
    Indian J Gastroenterol. 2020;39:9-21.
    PubMed     Abstract available

  29. WONG SW, Chan WK
    Epidemiology of non-alcoholic fatty liver disease in Asia.
    Indian J Gastroenterol. 2020;39:1-8.
    PubMed     Abstract available

  30. ELHENCE A, Shalimar
    Treatment of non-alcoholic fatty liver disease - Current perspectives.
    Indian J Gastroenterol. 2020;39:22-31.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.